His-bundle pacing: A novel treatment for left bundle branch block-mediated cardiomyopathy.


Journal

Journal of cardiovascular electrophysiology
ISSN: 1540-8167
Titre abrégé: J Cardiovasc Electrophysiol
Pays: United States
ID NLM: 9010756

Informations de publication

Date de publication:
10 2020
Historique:
received: 06 05 2020
revised: 12 07 2020
accepted: 20 07 2020
pubmed: 28 7 2020
medline: 29 7 2021
entrez: 27 7 2020
Statut: ppublish

Résumé

Chronic left bundle branch block (LBBB) can lead to LBBB-mediated cardiomyopathy from left ventricular dysynchrony. His-bundle pacing (HBP) results in direct electrical synchrony using the native His-Purkinje system, providing a novel treatment for this cardiomyopathy. To assess the feasibility of HBP for cardiac resynchronization therapy (CRT) in LBBB-mediated cardiomyopathy patients. Retrospective database review was conducted on patients who underwent CRT by the HBP capable provider at Indiana University Health and Eskenazi Hospital from August 2015 to August 2017. A subset of patients who met the predefined syndrome criteria of LBBB-mediated cardiomyopathy who underwent HBP were identified. Clinical, echocardiographic, and electrocardiographic variables were extracted at baseline and follow-up. Nine patients had cardiomyopathy and LBBB. Among those two were lost to follow-up. Seven patients were included in the analysis. The average time from device implantation to the last follow-up was 14.5 months. Left ventricular ejection fraction improved on average from 25% to 50% (p = .0001). The left ventricular end-systolic dimension decreased from 47 to 37 mm (p = .003) and the left ventricular end-diastolic dimension decreased from 55 to 48 mm (p = .03). QRS duration with HBP-CRT decreased from 152 to 115 ms. New York Heart Association classification improved from an average of 2.7-2. HBP is a viable technique for pursuing CRT in patients with LBBB-mediated cardiomyopathy.

Sections du résumé

BACKGROUND
Chronic left bundle branch block (LBBB) can lead to LBBB-mediated cardiomyopathy from left ventricular dysynchrony. His-bundle pacing (HBP) results in direct electrical synchrony using the native His-Purkinje system, providing a novel treatment for this cardiomyopathy.
OBJECTIVE
To assess the feasibility of HBP for cardiac resynchronization therapy (CRT) in LBBB-mediated cardiomyopathy patients.
METHODS
Retrospective database review was conducted on patients who underwent CRT by the HBP capable provider at Indiana University Health and Eskenazi Hospital from August 2015 to August 2017. A subset of patients who met the predefined syndrome criteria of LBBB-mediated cardiomyopathy who underwent HBP were identified. Clinical, echocardiographic, and electrocardiographic variables were extracted at baseline and follow-up.
RESULTS
Nine patients had cardiomyopathy and LBBB. Among those two were lost to follow-up. Seven patients were included in the analysis. The average time from device implantation to the last follow-up was 14.5 months. Left ventricular ejection fraction improved on average from 25% to 50% (p = .0001). The left ventricular end-systolic dimension decreased from 47 to 37 mm (p = .003) and the left ventricular end-diastolic dimension decreased from 55 to 48 mm (p = .03). QRS duration with HBP-CRT decreased from 152 to 115 ms. New York Heart Association classification improved from an average of 2.7-2.
CONCLUSION
HBP is a viable technique for pursuing CRT in patients with LBBB-mediated cardiomyopathy.

Identifiants

pubmed: 32713017
doi: 10.1111/jce.14692
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2730-2736

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29(2):270-276. https://doi.org/10.1093/eurheartj/ehm342
Bozkurt B, Colvin M, Cook J, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation. 2016;134(23):e579-e646. https://doi.org/10.1161/CIR.0000000000000455
Sanna GD, Merlo M, Moccia E, et al. Left bundle branch block-induced cardiomyopathy: a diagnostic proposal for a poorly explored pathological entity. Int J Cardiol. 2020;299:199-205. https://doi.org/10.1016/j.ijcard.2019.06.008
Fahy GJ, Pinski SL, Miller DP, et al. Natural history of isolated bundle branch block. Am J Cardiol. 1996;77(14):1185-1190. https://doi.org/10.1016/s0002-9149(96)00160-9
Sze E, Dunning A, Loring Z, et al. Comparison of incidence of left ventricular systolic dysfunction among patients with left bundle branch block versus those with normal QRS duration. Am J Cardiol. 2017;120(11):1990-1997. https://doi.org/10.1016/j.amjcard.2017.08.003
Sze E, Samad Z, Dunning A, et al. Impaired recovery of left ventricular function in patients with cardiomyopathy and left bundle branch block. J Am Coll Cardiol. 2018;71(3):306-317. https://doi.org/10.1016/j.jacc.2017.11.020
Wang NC, Singh M, Adelstein EC, et al. New-onset left bundle branch block-associated idiopathic nonischemic cardiomyopathy and left ventricular ejection fraction response to guideline-directed therapies: the NEOLITH study. Heart Rhythm. 2016;13(4):933-942. https://doi.org/10.1016/j.hrthm.2015.12.020
Witt CM, Wu G, Yang D, Hodge DO, Roger VL, Cha Y-M. Outcomes with left bundle branch block and mildly to moderately reduced left ventricular function. JACC Heart Fail. 2016;4(11):897-903. https://doi.org/10.1016/j.jchf.2016.07.002
Grines CL, Bashore TM, Boudoulas H, Olson S, Shafer P, Wooley CF. Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony. Circulation. 1989;79(4):845-853. https://doi.org/10.1161/01.cir.79.4.845
Vernooy K, Verbeek XA, Peschar M, et al. Left bundle branch block induces ventricular remodelling and functional septal hypoperfusion. Eur Heart J. 2005;26(1):91-98. https://doi.org/10.1093/eurheartj/ehi008
Blanc J-J, Fatemi M, Bertault V, Baraket F, Etienne Y. Evaluation of left bundle branch block as a reversible cause of non-ischaemic dilated cardiomyopathy with severe heart failure. A new concept of left ventricular dyssynchrony-induced cardiomyopathy. Europace. 2005;7(6):604-610. https://doi.org/10.1016/j.eupc.2005.06.005
Vaillant C, Martins RP, Donal E, et al. Resolution of left bundle branch block-induced cardiomyopathy by cardiac resynchronization therapy. J Am Coll Cardiol. 2013;61(10):1089-1095. https://doi.org/10.1016/j.jacc.2012.10.053
Thosani AJ, Liu E, Shaw G, Belden W, Chenarides J. Rapid reversal of right ventricular pacing-induced cardiomyopathy by His bundle pacing. HeartRhythm Case Rep. 2017;3(3):189-191. https://doi.org/10.1016/j.hrcr.2017.01.004
Teng AE, Lustgarten DL, Vijayaraman P, et al. Usefulness of His bundle pacing to achieve electrical resynchronization in patients with complete left bundle branch block and the relation between native QRS axis, duration, and normalization. Am J Cardiol. 2016;118(4):527-534. https://doi.org/10.1016/j.amjcard.2016.05.049
Sharma PS, Dandamudi G, Naperkowski A, et al. Permanent His-bundle pacing is feasible, safe, and superior to right ventricular pacing in routine clinical practice. Heart Rhythm. 2015;12(2):305-312. https://doi.org/10.1016/j.hrthm.2014.10.021
Kean AC, Kay WA, Patel JK, Miller JM, Dandamudi G. Permanent nonselective His bundle pacing in an adult with L-transposition of the great arteries and complete AV block. Pacing Clin Electrophysiol. 2017;40(11):1313-1317. https://doi.org/10.1111/pace.13107
Wang NC, Li JZ, Adelstein EC, et al. New-onset left bundle branch block-associated idiopathic nonischemic cardiomyopathy and time from diagnosis to cardiac resynchronization therapy: the NEOLITH II study. Pacing Clin Electrophysiol. 2018;41(2):143-154. https://doi.org/10.1111/pace.13264
Wagner GS, Macfarlane P, Wellens H, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part VI: acute ischemia/infarction: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol. 2009;53(11):1003-1011. https://doi.org/10.1016/j.jacc.2008.12.016
Dandamudi G, Vijayaraman P. How to perform permanent His bundle pacing in routine clinical practice. Heart Rhythm. 2016;13(6):1362-1366. https://doi.org/10.1016/j.hrthm.2016.03.040
Dandamudi G, Vijayaraman P. History of His bundle pacing. J Electrocardiol. 2017;50(1):156-160. https://doi.org/10.1016/j.jelectrocard.2016.09.011
Ajijola OA, Upadhyay GA, Macias C, Shivkumar K, Tung R. Permanent His-bundle pacing for cardiac resynchronization therapy: initial feasibility study in lieu of left ventricular lead. Heart Rhythm. 2017;14(9):1353-1361. https://doi.org/10.1016/j.hrthm.2017.04.003
Arnold AD, Shun-Shin MJ, Keene D, et al. His resynchronization versus biventricular pacing in patients with heart failure and left bundle branch block. J Am Coll Cardiol. 2018;72(24):3112-3122. https://doi.org/10.1016/j.jacc.2018.09.073
Huang W, Su L, Wu S, et al. Long-term outcomes of His bundle pacing in patients with heart failure with left bundle branch block. Heart Br Card Soc. 2019;105(2):137-143. https://doi.org/10.1136/heartjnl-2018-313415
Sharma PS, Dandamudi G, Herweg B, et al. Permanent His-bundle pacing as an alternative to biventricular pacing for cardiac resynchronization therapy: a multicenter experience. Heart Rhythm. 2018;15(3):413-420. https://doi.org/10.1016/j.hrthm.2017.10.014
Upadhyay GA, Vijayaraman P, Nayak HM, et al. His corrective pacing or biventricular pacing for cardiac resynchronization in heart failure. J Am Coll Cardiol. 2019;74(1):157-159. https://doi.org/10.1016/j.jacc.2019.04.026
Zhang Q, Zhou Y, Yu C-M. Incidence, definition, diagnosis, and management of the cardiac resynchronization therapy nonresponder. Curr Opin Cardiol. 2015;30(1):40-49. https://doi.org/10.1097/HCO.0000000000000140
Cleland JG, Abraham WT, Linde C, et al. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J. 2013;34(46):3547-3556. https://doi.org/10.1093/eurheartj/eht290
Burns KV, Gage RM, Curtin AE, Bank AJ. Long-term echocardiographic response to cardiac resynchronization therapy in initial nonresponders. JACC Heart Fail. 2015;3(12):990-997. https://doi.org/10.1016/j.jchf.2015.09.006
Ypenburg C, van Bommel RJ, Borleffs CJ, et al. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. J Am Coll Cardiol. 2009;53(6):483-490. https://doi.org/10.1016/j.jacc.2008.10.032
Vernooy K, Cornelussen RNM, Verbeek XAAM, et al. Cardiac resynchronization therapy cures dyssynchronopathy in canine left bundle-branch block hearts. Eur Heart J. 2007;28(17):2148-2155. https://doi.org/10.1093/eurheartj/ehm207
Wang NC, Adelstein EC, Singh M, Voigt AH, Saba S. Left bundle branch block-associated cardiomyopathies and early cardiac resynchronization therapy: conceptualizing a tailored approach. J Am Coll Cardiol. 2018;71(17):1943-1944. https://doi.org/10.1016/j.jacc.2018.02.060

Auteurs

Rajeev Singh (R)

Department of Cardiology, Washington University, St. Louis, Missouri, USA.

Subodh Devabhaktuni (S)

Department of Cardiology, University of Arkansas Medical Sciences, Little Rock, Arkansas, USA.

Fatima Ezzeddine (F)

Department of Cardiology, Mayo Clinic, Rochester, Minnesota, USA.

Joel Simon (J)

Department of Cardiology, Indiana University Health, Indianapolis, Indiana, USA.

Kavita Khaira (K)

Department of Cardiology, Indiana University Health, Indianapolis, Indiana, USA.

Gopi Dandamudi (G)

Department of Cardiology, CHI Pacific North West, Tacoma, Washington, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH